Cargando…

Treatment of Non-Infectious Posterior Uveitis with Dexamethasone Intravitreal Implants in a Real-World Setting

PURPOSE: The present study aimed to assess the efficacy and safety associated to the treatment of patients with non-infectious posterior uveitis with intravitreal dexamethasone (DEX) implants in a real-world clinical setting. PATIENTS AND METHODS: This is a retrospective, single center analysis of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butt, Farhat, Devonport, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940496/ https://www.ncbi.nlm.nih.gov/pubmed/36814784 http://dx.doi.org/10.2147/OPTH.S393662

Ejemplares similares

Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis
por: Hasanreisoğlu, Murat, et al.
Publicado: (2019)

Intravitreal dexamethasone implant results in the treatment of non-infectious uveitis
por: Dikmen, Nejla Tukenmez, et al.
Publicado: (2022)

Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Myung, Jane S, et al.
Publicado: (2010)

Real-Life Efficacy, Safety, and Use of Dexamethasone Intravitreal Implant in Posterior Segment Inflammation Due to Non-infectious Uveitis (LOUVRE 2 Study)
por: Bodaghi, Bahram, et al.
Publicado: (2022)

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter, Rebecca S, et al.
Publicado: (2011)

Long-Acting Fluocinolone Acetonide Intravitreal Implant for Recurrent Bilateral Non-Infectious Posterior Uveitis
por: Babel, Adrian T, et al.
Publicado: (2022)

Efficacy of intravitreal dexamethasone implant used as monotherapy for the treatment of macular edema in non-infectious uveitis: a retrospective analysis
por: Gupta, Rishi B., et al.
Publicado: (2023)

The Use of Sustained Release Intravitreal Steroid Implants in Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
por: Abdulla, Didar, et al.
Publicado: (2022)

Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis
por: Elhamaky, Tarek R
Publicado: (2022)

Intravitreal Dexamethasone Implant in the Treatment of Non-Infectious Uveitic Macular Edema
por: Karti, Omer, et al.
Publicado: (2018)

Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2021)

Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis
por: Hikal, Muaas, et al.
Publicado: (2021)

Repeat Intravitreal Dexamethasone Implant for Refractory Cystoid Macular Edema in Syphilitic Uveitis
por: Lautredou, Cassandra C., et al.
Publicado: (2018)

Dexamethasone intravitreal implant for macular edema and some other rare indications in uveitis
por: Koksaldi, Seher, et al.
Publicado: (2023)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review
por: Kishore, Kamal, et al.
Publicado: (2022)

Non-infectious uveitis affecting the posterior segment treated with fluocinolone acetonide intravitreal implant: 3-year fellow eye analysis
por: Pavesio, Carlos, et al.
Publicado: (2021)

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
por: Tufail, Adnan, et al.
Publicado: (2018)

Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
por: Zarranz-Ventura, Javier, et al.
Publicado: (2019)

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion
por: Ryder, Steven J, et al.
Publicado: (2015)

Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment
por: Steeples, Laura R, et al.
Publicado: (2021)

Management of noninfectious posterior uveitis with intravitreal drug therapy
por: Tan, Hui Yi, et al.
Publicado: (2016)

Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months
por: Moll-Udina, Aina, et al.
Publicado: (2023)

Real-world experience on intravitreal dexamethasone implant in patients with macular edema scheduled to undergo cataract surgery
por: Lai, Chun-Chieh, et al.
Publicado: (2023)

Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye – evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN(®))
por: Bodaghi, Bahram, et al.
Publicado: (2020)

Intravitreal dexamethasone implants for the treatment of refractory scleritis combined with uveitis in adult-onset Still’s disease: a case report
por: Ahn, Seong Joon, et al.
Publicado: (2016)

Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant
por: Sheppard, John D, et al.
Publicado: (2012)

Intravitreal dexamethasone implant — a new treatment for idiopathic posterior scleritis: A case report
por: Zhao, Yong-Ji, et al.
Publicado: (2021)

The corneal effects of intravitreal dexamethasone implantation
por: Bayat, Alper Halil, et al.
Publicado: (2020)

Intravitreal Dexamethasone Implant in Autoimmune Retinopathy
por: Bordin, Fernando Longhi, et al.
Publicado: (2023)

Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
por: Lam, Wai-Ching, et al.
Publicado: (2015)

Ozurdex (dexamethasone intravitreal implant) for the treatment of intermediate, posterior, and panuveitis: a systematic review of the current evidence
por: Saincher, Saanwalshah Samir, et al.
Publicado: (2020)

Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema
por: Rishi, Pukhraj, et al.
Publicado: (2020)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

Intravitreal Dexamethasone Implant (Ozurdex) in Coats’ Disease
por: Saatci, Ali Osman, et al.
Publicado: (2013)

Cytomegalovirus retinitis following dexamethasone intravitreal implant
por: Chaudhry, Sarah G., et al.
Publicado: (2021)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea
por: Kim, Min Seok, et al.
Publicado: (2021)

Dexamethasone implants in paediatric patients with noninfectious intermediate or posterior uveitis: first prospective exploratory case series
por: Winterhalter, Sibylle, et al.
Publicado: (2017)

Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019)

Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye
por: Mikhail, Michael, et al.
Publicado: (2013)

Can the dexamethasone intravitreal implant Ozurdex be safely administered in an out-of-operating room setting?
por: Cidad-Betegón, María del Pino, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nt7rcc1v5pmfpcnr5r472fqu1a